Friday June 27, 2014. The National Business Review article link here. A local sleeper medical technology company has ambitious plans to move into commercial production, and won’t rule out an initial public offering. Reporter David Williams looks into how the up and coming tech company are developing a smart device to remotely monitor how people with asthma and other […]
Link here. Presentation overview: • FY2014 Financial Review • The Market / Industry Overview • Business Update
Australia, 11 June 2014. ASX announcement here.
MELBOURNE, Australia – June 05, 2014 – Nexvet Biopharma, a leading veterinary biologic drug developer, today announced the oral presentation of data related to clinical development of NV-01, a … Down load article here.
Nexus6 Ltd, has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for its new SmartTouch inhaler monitoring device. June 3rd, 2014. Link here. It is well known that it is difficult for patients to remember to take daily preventative medications over a long term as required for the management of many chronic […]
NZX & Media Release 30 May 2014. Link here. Financial results for the year to 31 March 2014 Highlights: • Significant new squalene sales contract demonstrates the benefits of a secure raw material supply • Making good progress on the new refined fish oil plant in Nelson • Financially well positioned with $5.2m of cash on hand […]
RICHMOND, VA, US, LJUBLJANA, SLOVENIA and SYDNEY, AUSTRALIA, May 22, 2014 Link here. AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election […]
Link here. RICHMOND, VA, US, LJUBLJANA, SLOVENIA and SYDNEY, AUSTRALIA, May 22, 2014 –AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election to […]
Australia, 20 May 2014. Link here. Read more about Avita Medical appoints new Chairman
Link here. Highlights · Clinical study interim results demonstrate ReCell® superiority as treatment for hypopigmentation. · Statistically significant pigment restored in patients’ hypopigmented scars treated with ReCell. · Results support the Company’s commercial strategy for use of ReCell in aesthetic plastic surgery. · Study results delivered at key European conferences, enhancing ReCell industry profile. Northridge, Calif., […]